BTG1 Mutation Correlates with Inferior Prognosis in Diffuse Large B-Cell Lymphoma
BTG1 mutation was promising prognostic predictor for DLBCL. The mechanism driving different survival outcomes may be attributed to the tumor metabolic reprogramming.
Authors
- Wei Xu (ORCID: https://orcid.org/0000-0003-4208-7477)
- Hao-Rui Shen (ORCID: https://orcid.org/0000-0003-4330-850X)
- Rui Gao (ORCID: https://orcid.org/0000-0002-0845-1370)
- Yifan Wu (ORCID: https://orcid.org/0000-0002-8498-8436)
- Kai‐Xin Du (ORCID: https://orcid.org/0000-0002-9689-2298)
- Li Wang (ORCID: https://orcid.org/0000-0001-5232-3846)
- Yue Li (ORCID: https://orcid.org/0000-0003-4547-064X)
- Wei Hua (ORCID: https://orcid.org/0000-0002-2047-9712)
- Jianyong Li (ORCID: https://orcid.org/0000-0002-9931-4055)
- Jinhua Liang
- Hua Yin
- Tong‐Yao Xing
- Chunyu Shang (ORCID: https://orcid.org/0009-0001-5637-3629)
Institutions
- Jiangsu Province Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Cancer Research and Treatment
- Published
- 2025-07-30
- DOI
- https://doi.org/10.4143/crt.2025.494
- Primary Topic
- Cancer-related gene regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Government of Jiangsu Province
- Jiangsu Science and Technology Department